pf-07081532
Showing 1 - 9 of 9
Healthy Trial (Dabigatran etexilate (DE), Rosuvastatin, PF-07081532)
Not yet recruiting
- Healthy
- Dabigatran etexilate (DE)
- +2 more
- (no location specified)
Mar 15, 2023
Healthy Trial in New Haven (PF-07081532, Cyclosporine, Itraconazole)
Recruiting
- Healthy
- PF-07081532
- +2 more
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Mar 2, 2023
Obesity Trial in Anaheim (PF-07081532, Semaglutide)
Recruiting
- Obesity
- PF-07081532
- Semaglutide
-
Anaheim, CaliforniaAnaheim Clinical Trials, LLC
Jan 27, 2023
Type 2 Diabetes, Renal Impairment Trial in Tampa (PF-07081532)
Not yet recruiting
- Type 2 Diabetes
- Renal Impairment
- PF-07081532
-
Tampa, FloridaGenesis Clinical Research
Aug 19, 2022
Hepatic Impairment, Healthy Volunteers Trial in Orlando, Tampa (PF-07081532)
Not yet recruiting
- Hepatic Impairment
- Healthy Volunteers
- PF-07081532
-
Orlando, Florida
- +1 more
Jul 26, 2022
Type 2 Diabetes Trial in South Miami (PF-07081532, Placebo)
Completed
- Type 2 Diabetes Mellitus
- PF-07081532
- Placebo
-
South Miami, FloridaQps-Mra, Llc
Jun 28, 2022
Diabetes Type 2 Trial in Anaheim, South Miami (PF-07081532, Placebo, Clopidogrel)
Completed
- Diabetes Mellitus Type 2
- PF-07081532
- +2 more
-
Anaheim, California
- +1 more
Sep 21, 2021
Diabetes, Obesity Trial in Worldwide (PF-07081532, Placebo, Rybelsus)
Recruiting
- Diabetes Mellitus
- Obesity
- PF-07081532
- +2 more
-
Centreville, Alabama
- +55 more
Jan 18, 2023
Healthy Trial in Brussels (PF-07081532, Placebo)
Completed
- Healthy
- PF-07081532
- Placebo
-
Brussels, Bruxelles-capitale, RĂ©gion DE, BelgiumBrussels Clinical Research Unit
Mar 23, 2020